Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Washoe Cancer Services at Washoe Medical Center - Reno
mi
from
Reno, NV
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Washoe Cancer Services at Washoe Medical Center - Reno
mi
from
Reno, NV
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Fox Chase Virtua Health Cancer Program - Marlton
mi
from
Marlton, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Fox Chase Virtua Health Cancer Program - Marlton
mi
from
Marlton, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Community Regional Cancer Center at Community Medical Center
mi
from
Toms River, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Regional Cancer Center at Community Medical Center
mi
from
Toms River, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Akron City Hospital
mi
from
Akron, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Cancer Treatment Center
mi
from
Wooster, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Paoli Memorial Hospital
mi
from
Paoli, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
LDS Hospital
mi
from
Salt Lake City, UT
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated:  11/16/2015
Stanford/VA Palo Alto Mood Disorder Research Program
mi
from
Palo Alto, CA
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated: 11/16/2015
Stanford/VA Palo Alto Mood Disorder Research Program
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
City of Hope National Medical Center
mi
from
Duarte, CA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
University of Florida College of Medicine
mi
from
Gainesville, FL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Emory University
mi
from
Atlanta, GA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Rush University Medical Center
mi
from
Chicago, IL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
University Hospitals of Cleveland/Case Western
mi
from
Cleveland, OH
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University Hospitals of Cleveland/Case Western
mi
from
Cleveland, OH
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Oregon Health and Science University
mi
from
Portland, OR
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Fox Chase, Temple University
mi
from
Philadelphia, PA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Fox Chase, Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Baylor College of Medicine/The Methodist Hospital
mi
from
Houston, TX
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Baylor College of Medicine/The Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
Virginia Commonwealth University, MCV Hospital
mi
from
Richmond, VA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Virginia Commonwealth University, MCV Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
Progesterone for the Treatment of Cocaine Dependence - 1
Interactions Between Progesterone and Cocaine in Women
Status: Enrolling
Updated:  11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Progesterone for the Treatment of Cocaine Dependence - 1
Interactions Between Progesterone and Cocaine in Women
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Dothan, AL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Santa Ana, CA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Washington,
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Bradenton, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Hialeah, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials